Lv02
0 积分 2024-03-30 加入
The management of oligometastatic disease in colorectal cancer: Present strategies and future perspectives
1小时前
待确认
Liver transplantation for non-resectable colorectal liver metastases: the International Hepato-Pancreato-Biliary Association consensus guidelines
2小时前
已完结
Liver transplantation plus chemotherapy versus chemotherapy alone in patients with permanently unresectable colorectal liver metastases (TransMet): results from a multicentre, open-label, prospective, randomised controlled trial
2小时前
已完结
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study
3小时前
已完结
Stereotactic body radiotherapy for oligometastatic disease: current evidence and future perspectives
3小时前
已关闭
Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC–ESTRO OligoCare consortium
3小时前
已完结
The management of oligometastatic disease in colorectal cancer: Present strategies and future perspectives
4小时前
已完结
Chemotherapy With or Without Anti-EGFR Agents in Left- and Right-Sided Metastatic Colorectal Cancer: An Updated Meta-Analysis
1天前
已关闭
Primary tumour side as a driver for treatment choice in RAS wild-type metastatic colorectal cancer patients: a systematic review and pooled analysis of randomised trials
1天前
已完结
Prognostic differences between oligometastatic and polymetastatic disease after resection in patients with colorectal cancer and hepatic or lung metastases: Retrospective analysis of a large cohort at a single institution
1天前
已完结
皖公网安备34019202002308
